TrimRx's Blog

PT-141 has a more substantial evidence base than most peptides marketed by wellness clinics.

PT-141 works on the brain, not the blood vessels. That single fact separates it from every other approved sexual function drug.

The FDA-approved dose of bremelanotide (Vyleesi) is 1.75 mg subcutaneously, no more than once in 24 hours, no more than 8 times in 28 days.

PT-141, marketed as Vyleesi by Palatin Technologies, is the only melanocortin receptor agonist FDA-approved for a sexual dysfunction indication.

Introduction The standard protein recommendation for adults (0.36 g per pound, the US RDA) was set in the 1940s based on nitrogen balance studies…

DEXA substudies of the STEP and SURMOUNT trials put a number on the lean-mass question.

Stopping a GLP-1 without a plan is the single biggest reason people regain weight. The STEP 1 trial extension (Wilding et al.

Plenity and TrimRx attract very different review patterns because the products work very differently.

Almost everyone on a GLP-1 hits a plateau eventually. The question is when and what you can do about it.